SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
摘要:
SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor. This compound displays nanomolar affinity for the central cannabinoid receptor but is not active on the peripheral cannabinoid receptor. In vitro, SR141716A antagonises the inhibitory effects of cannabinoid receptor agonists on both mouse vas deferens contractions and adenylyl cyclase activity in rat brain membranes. After intraperitoneal or oral administration SR141716A antagonises classical pharmacological and behavioural effects of cannabinoid receptor agonists. This compound should prove to be a powerful tool for investigating the in vivo functions of the anandamide/cannabinoid system.
展开
关键词:
Cannabinoid receptor Receptor antagonist cAMP Behavioural responses Tris, Tris-[hydroxymethyl]aminomethane, Δ9-THC, tetrahydrocannabinol i.p., intraperitoneal p.o., per os i.v., intravenous CHO, chinese hamster ovary
DOI:
10.1016/0014-5793(94)00773-X
被引量:
年份:
1994


































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!